RightFit
Not yet recruitingNot applicable

Expanding Genetic Access for Prostate Cancer Survivors

Expanding Genetic Access and Guided Education for Prostate Cancer Survivors

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
18 Years to 80 Years
Sex
Male only
Healthy volunteers
Not accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

Not stated in the study description — ask the study team about visits and procedures.

Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This study is for prostate cancer survivors. It compares a digital guide, a printed guide, and usual care with added support to see which helps more people learn about and get testing for inherited cancer risk. It also looks at how these approaches affect choices and well-being.

The goal of this study is to increase genetic education and genetic testing for hereditary cancer risk among prostate cancer survivors. The study will: Test the effectiveness of a digital guide (DG+) vs. print guide (Print+) vs. enhanced usual care (EUC) on engagement in genetic education and uptake of genetic testing. Evaluate the impact of the DG+ vs. Print+ vs. EUC on the process that participants use to make decisions and evaluate effects on well-being (also called psychosocial outcomes). Explore the ways (methods) that influence how participants experience the intervention. The main questions this study aims to answer are: which group - the digital guide (DG+) group, print (Print+) group or the EUC group - is more likely to request genetic testing and which group is more likely to get (engage with) genetic education. Participants will be randomly assigned to either the digital guide (DG+) group, the print guide (Print+) group or EUC group. Each group will receive genetic education and have an opportunity to request genetic testing. Researchers will compare the three groups to determine which is most most likely to complete genetic testing (GT) and which group engages more with genetic education.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • Are 18 to 80 years old.
  • Were diagnosed with prostate cancer at least 6 months ago.
  • Have not had genetic testing for inherited cancer risk.
  • Received care at a study site within the past 5 years.
  • Meet National Comprehensive Cancer Network guidelines for testing for gene changes passed down in families.
  • Can read and speak English.
  • Can give informed consent, meaning you understand the study and agree to join.
  • Have internet access on a smartphone, tablet, or computer and feel comfortable using a computer or phone on your own to find information.

Who can't join

  • Do not speak English.
  • Cannot access the internet.
  • Have already had genetic testing for inherited cancer risk, or had genetic counseling and then chose not to get testing.
  • Cannot give informed consent, meaning you cannot understand the study and agree to join.

Simplified for readability. The official criteria below are what the study team uses.

Official eligibility criteria

Inclusion Criteria: * 18-80 years of age * At least 6-months post diagnosis with prostate cancer * Have not had genetic testing for hereditary cancer * Have received care at one of the participating sites in the prior five years * Meet National Comprehensive Cancer Network criteria for germline GT * Able to read and speak in English * Capable of providing informed consent * Have internet access (via smartphone, tablet or computer) * Comfortable using a computer or mobile phone independently to access information Exclusion Criteria: * Do not speak English * Unable to access the Internet * Have previously undergone germline genetic testing for hereditary cancer risk or previously had genetic counseling (GC) and declined genetic testing (GT) * Are unable to provide informed consent

Study sites (2)

DC

NJ